ORKA logo
ORKA NASDAQ US

Oruka Therapeutics, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Jul 2000
$53.31
▲ +$2.88 (+5.71%)
Vol 1.6M
3
Quality Score
fail
Mkt Cap
$1.5B
ROE
-25.8%
Margin
-26.3%
D/E
0.00
Beta
-0.43
52W
$5–$33

Wall Street Consensus

20 analysts · Apr 2026
9
Strong Buy
10
Buy
1
Hold
0
Sell
0
Strong Sell
95.0%
Buy Rating

Price Chart

Similar Stocks

VERA
Vera Therapeutics, Inc
$3.5B
IDYA
IDEAYA Biosciences Inc
$3.0B
TVTX
Travere Therapeutics Inc
$3.4B
VCYT
Veracyte Inc
P/E 110.3
$3.3B
BEAM
Beam Therapeutics Inc
$2.8B
IRON
Disc Medicine Inc
$3.0B
KOD
Kodiak Sciences Inc
$1.7B
IMNM
Immunome Inc
$2.4B
SRPT
Sarepta Therapeutics Inc
$2.3B

Earnings

Beat rate: 100.0%
Next Report May 12, 2026
EPS Estimate: $-0.56
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.56 — —
Dec 2025 $-0.64 $-0.45 +$0.19
Sep 2025 $-0.59 $-0.55 +$0.04
Jun 2025 $-0.50 $-0.46 +$0.04

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -26.9% -26.9% -26.9% -26.9% -25.8% -25.8%
P/E (TTM) — — — — — —
Net Margin — -26.3% -26.3% -26.3% -26.3% -26.3%
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 27.42 27.42 27.42 27.42 16.94 16.94

Key Ratios

ROA (TTM)
-24.8%
P/S (TTM)
31.31
P/B
1.8
EPS (TTM)
$-2.36
52W High
$32.64
52W Low
$5.49
$5.49 52-Week Range $32.64

How does ORKA compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

ORKA AAPG ABEO ABOS ABP

ORKA valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
31.3
▲ 144% above peers (12.9)
vs Peers
vs Industry
Pricier
P/B ratio
1.8
▼ 28% below peers (2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

ORKA profitability vs Biotechnology peers

ROE
-25.8%
▲ 62% above peers (-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-26.3%
▲ 91% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-24.8%
▲ 47% above peers (-46.7%)
vs Peers
vs Industry
Top tier

ORKA financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
16.9
▲ 282% above peers (4.4)
vs Peers
vs Industry
Strong liquidity
Beta
-0.4
▼ 144% below peers (1.0)
vs Peers
vs Industry
More volatile

ORKA fundamentals radar

ORKA Peer median Industry

ORKA profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

ORKA vs peers: key metrics

Latest News

VR Adviser Adds Over 1 Million Savara Shares
Yahoo Finance · Mar 17